| Adedotun Daniyan, PMHNP-BC | |
|
9654 Baron Pl, Baltimore, MD 21237-4122 | |
| (410) 686-6273 | |
| Not Available |
| Full Name | Adedotun Daniyan |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 9654 Baron Pl, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679144075 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0808X | Clinical Nurse Specialist - Psychiatric/mental Health | R210991 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Della Behavioral Health Services | 3971755000 | 52 |
News Archive
For more than 100 years, the traditional treatment for the painful growths called gallstones has been removal of the gallbladder, or cholecystectomy. But a new device, patented in China, promises to make removing the entire organ unnecessary. A group of scientists from the Second People's Hospital of Panyu District and Central South University in China have developed an endoscope specially designed for locating and clearing out gallstones and other gallbladder lesions.
A recently discovered protein complex known as STING plays a crucial role in detecting the presence of tumor cells and promoting an aggressive anti-tumor response by the body's innate immune system, according to two separate studies published in the Nov. 20 issue of the journal Immunity.
Getinge (STO:GETIB) has secured 78.55% of the outstanding shares in Pulsion Medical Systems. All conditions precedent stipulated in the offer document have been met and the transaction was completed yesterday. Pulsion will be consolidated in Getinge's accounts as of March 1 2014.
"Grand Challenges Canada just announced grants of $100,000 for 102 imaginative new ideas to tackle health problems in resource-poor countries," Inter Press Service reports, noting, "Of these, 59 grants went to researchers in 13 low- and middle-income nations worldwide."
Today AIDS Healthcare Foundation (AHF), the largest global AIDS organization, blasted the news that Gilead Sciences Inc. increased the prices of several of its top selling products at the beginning of the month. The California-based drug maker increased the price of its biggest seller, HIV treatment Atripla, by 5.1%. Gilead also raised the price of HIV drugs Truvada and Emtriva by 7.9%.
› Verified 8 days ago
| Entity Name | Della Behavioral Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750635207 PECOS PAC ID: 3971755000 Enrollment ID: O20121218000204 |
News Archive
For more than 100 years, the traditional treatment for the painful growths called gallstones has been removal of the gallbladder, or cholecystectomy. But a new device, patented in China, promises to make removing the entire organ unnecessary. A group of scientists from the Second People's Hospital of Panyu District and Central South University in China have developed an endoscope specially designed for locating and clearing out gallstones and other gallbladder lesions.
A recently discovered protein complex known as STING plays a crucial role in detecting the presence of tumor cells and promoting an aggressive anti-tumor response by the body's innate immune system, according to two separate studies published in the Nov. 20 issue of the journal Immunity.
Getinge (STO:GETIB) has secured 78.55% of the outstanding shares in Pulsion Medical Systems. All conditions precedent stipulated in the offer document have been met and the transaction was completed yesterday. Pulsion will be consolidated in Getinge's accounts as of March 1 2014.
"Grand Challenges Canada just announced grants of $100,000 for 102 imaginative new ideas to tackle health problems in resource-poor countries," Inter Press Service reports, noting, "Of these, 59 grants went to researchers in 13 low- and middle-income nations worldwide."
Today AIDS Healthcare Foundation (AHF), the largest global AIDS organization, blasted the news that Gilead Sciences Inc. increased the prices of several of its top selling products at the beginning of the month. The California-based drug maker increased the price of its biggest seller, HIV treatment Atripla, by 5.1%. Gilead also raised the price of HIV drugs Truvada and Emtriva by 7.9%.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adedotun Daniyan, PMHNP-BC 9654 Baron Pl, Baltimore, MD 21237-4122 Ph: (410) 686-6273 | Adedotun Daniyan, PMHNP-BC 9654 Baron Pl, Baltimore, MD 21237-4122 Ph: (410) 686-6273 |
News Archive
For more than 100 years, the traditional treatment for the painful growths called gallstones has been removal of the gallbladder, or cholecystectomy. But a new device, patented in China, promises to make removing the entire organ unnecessary. A group of scientists from the Second People's Hospital of Panyu District and Central South University in China have developed an endoscope specially designed for locating and clearing out gallstones and other gallbladder lesions.
A recently discovered protein complex known as STING plays a crucial role in detecting the presence of tumor cells and promoting an aggressive anti-tumor response by the body's innate immune system, according to two separate studies published in the Nov. 20 issue of the journal Immunity.
Getinge (STO:GETIB) has secured 78.55% of the outstanding shares in Pulsion Medical Systems. All conditions precedent stipulated in the offer document have been met and the transaction was completed yesterday. Pulsion will be consolidated in Getinge's accounts as of March 1 2014.
"Grand Challenges Canada just announced grants of $100,000 for 102 imaginative new ideas to tackle health problems in resource-poor countries," Inter Press Service reports, noting, "Of these, 59 grants went to researchers in 13 low- and middle-income nations worldwide."
Today AIDS Healthcare Foundation (AHF), the largest global AIDS organization, blasted the news that Gilead Sciences Inc. increased the prices of several of its top selling products at the beginning of the month. The California-based drug maker increased the price of its biggest seller, HIV treatment Atripla, by 5.1%. Gilead also raised the price of HIV drugs Truvada and Emtriva by 7.9%.
› Verified 8 days ago
Brooke Adams Vacovsky, MSN, RN, AGCNS-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2401 W Belvedere Ave, Baltimore, MD 21215 Phone: 410-601-8133 | |
Jennifer Helzer, APRN-CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-350-7234 | |
Stephanie Morgenstern, APRN, ACCNS-P Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1800 Orleans St, Baltimore, MD 21287 Phone: 339-235-0624 | |
Megan Wanzer, DNP, CRNP, CNS, CCRN Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-5382 | |
Mr. Timothy Henrique Anthony Madeira, CRNP, APRN-CNS Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-5080 | |
Elizabeth K Zink, MS, RN, CCNS, CNRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1800 Orleans St Rm 3074, Baltimore, MD 21287 Phone: 410-955-5253 | |
Kenneth G Muthee, Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 1340 Smith Ave Ste 200, Baltimore, MD 21209 Phone: 443-500-9251 Fax: 410-779-1314 |